Amentum wins $112M nuclear decommissioning contract in Europe

Amentum won a €95.7M ($112M) EU contract to decommission nuclear research sites across Italy, Germany, Belgium and the Netherlands (initial 2-year term + three 2-year extensions). The company reported Q1 2026 EPS of $0.54 vs. $0.25 consensus (+116%) and revenue of $3.24B; S&P upgraded the rating to BB from BB- and Amentum repaid $750M of term loan debt in fiscal 2025. The deal, strong quarterly results and credit upgrade support upside for the $7.4B company, which InvestingPro notes still trades below its fair value.

Analysis

This contract win is best read as confirmation rather than a one-off: it deepens Amentum’s operational moat in European nuclear decommissioning and increases the probability of follow-on work from EU institutions and national programs. Decommissioning projects create long tail revenue (licensing, waste disposition, extended supervision) that converts into predictable, multi-year services revenue and cashflow — a structural improvement to revenue visibility that typically compresses effective funding costs for mid-credit engineering contractors.

Second-order beneficiaries are the specialized European supply chain (radiological waste transport, licensed waste storage, hot-cell dismantling specialists) which face higher utilization and pricing power over 12–36 months; conversely, commodity construction peers that depend on civil builds will see less incremental demand. Market structure also favors incumbents with existing site knowledge: winning teams reduce bid churn and push competitors to offer deeper discounts or accept lower margin profile to compete, which can compress industry-wide ROIC over time.

Key risks are execution and latent liability — permit reversals, waste classification disputes, or a single major technical delay can drive cost overruns and reputational damage over quarters to years. The realistic catalyst window is 6–18 months: expect incremental visible upside as backlog converts and next-year guidance is updated, but also lumpiness that can produce 10–20% volatility around milestone deliveries.

Key Decisions for Investors

• Long AMTM equity (tactical, 6–12 months): size 2–4% of portfolio, target +25% total return, stop-loss at -12%. Rationale: higher-margin, visible European services backlog should re-rate the multiple; use tranche entry on weakness.
• AMTM call spread (12 months): buy 1x ATM call and sell 1x OTM call ~20–30% above current price to finance premium. Reward: asymmetric upside if re-rating continues; capped cost limits downside to premium paid (expect hold 9–12 months).
• Pair trade (6–12 months): long AMTM / short Jacobs (J) equal dollar notional. Thesis: isolate pure-play decommissioning + services operational leverage vs broader integrator exposure; unwind if spread compresses >15% versus entry or if AMTM misses execution milestones.
• Credit trade (12 months): buy Amentum senior unsecured paper or select BB-rated industrial bond exposure (if direct bonds unavailable, use bond ETF exposure) to capture expected spread compression of ~75–150bps as backlog visibility and cash conversion improve. Size per credit limits; mark-to-market stop if negative rating action occurs.
• Tail hedge (protective): buy 6–9 month AMTM 10–15% OTM puts equal to 25% of equity longs to protect against project execution failure or abrupt regulatory risk that could reprice the stock by >20%.